36 related articles for article (PubMed ID: 26862059)
1. Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition.
Mitchell E; Jindal S; Chan T; Narasimhan J; Sivagnanam S; Gray E; Chang YH; Weinmann S; Schedin P
Mol Carcinog; 2020 Jul; 59(7):701-712. PubMed ID: 32134153
[TBL] [Abstract][Full Text] [Related]
2. Grading variation in 2,934 patients with ductal carcinoma in situ of the breast: the effect of laboratory- and pathologist-specific feedback reports.
van Dooijeweert C; van Diest PJ; Baas IO; van der Wall E; Deckers IAG
Diagn Pathol; 2020 May; 15(1):52. PubMed ID: 32393303
[TBL] [Abstract][Full Text] [Related]
3. Spatio-temporal modeling and live-cell imaging of proteolysis in the 4D microenvironment of breast cancer.
Ji K; Sameni M; Osuala K; Moin K; Mattingly RR; Sloane BF
Cancer Metastasis Rev; 2019 Sep; 38(3):445-454. PubMed ID: 31605250
[TBL] [Abstract][Full Text] [Related]
4. TGFβ-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression.
Gibson SV; Tomas Bort E; Rodríguez-Fernández L; Allen MD; Gomm JJ; Goulding I; Auf dem Keller U; Agnoletto A; Brisken C; Peck B; Cameron AJ; Marshall JF; Jones JL; Carter EP; Grose RP
NPJ Breast Cancer; 2023 Mar; 9(1):9. PubMed ID: 36864079
[TBL] [Abstract][Full Text] [Related]
5. Pitfalls in breast pathology.
Quinn C; Maguire A; Rakha E
Histopathology; 2023 Jan; 82(1):140-161. PubMed ID: 36482276
[TBL] [Abstract][Full Text] [Related]
6. Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ.
Ding L; Su Y; Fassl A; Hinohara K; Qiu X; Harper NW; Huh SJ; Bloushtain-Qimron N; Jovanović B; Ekram M; Zi X; Hines WC; Alečković M; Gil Del Alcazar C; Caulfield RJ; Bonal DM; Nguyen QD; Merino VF; Choudhury S; Ethington G; Panos L; Grant M; Herlihy W; Au A; Rosson GD; Argani P; Richardson AL; Dillon D; Allred DC; Babski K; Kim EMH; McDonnell CH; Wagner J; Rowberry R; Bobolis K; Kleer CG; Hwang ES; Blum JL; Cristea S; Sicinski P; Fan R; Long HW; Sukumar S; Park SY; Garber JE; Bissell M; Yao J; Polyak K
Nat Commun; 2019 Sep; 10(1):4182. PubMed ID: 31519911
[TBL] [Abstract][Full Text] [Related]
7. Discriminating the earliest stages of mammary carcinoma using myoepithelial and proliferative markers.
Duivenvoorden HM; Spurling A; O'Toole SA; Parker BS
PLoS One; 2018; 13(7):e0201370. PubMed ID: 30044853
[TBL] [Abstract][Full Text] [Related]
8. [Invasive carcinoma arising in breast microglandular adenosis: a clinicopathologic study of three cases and review of the literature].
Shui RH; Cheng YF; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):471-4. PubMed ID: 22088374
[TBL] [Abstract][Full Text] [Related]
9. Invasion in breast lesions: the role of the epithelial-stroma barrier.
Rakha EA; Miligy IM; Gorringe KL; Toss MS; Green AR; Fox SB; Schmitt FC; Tan PH; Tse GM; Badve S; Decker T; Vincent-Salomon A; Dabbs DJ; Foschini MP; Moreno F; Wentao Y; Geyer FC; Reis-Filho JS; Pinder SE; Lakhani SR; Ellis IO
Histopathology; 2018 Jun; 72(7):1075-1083. PubMed ID: 29197112
[TBL] [Abstract][Full Text] [Related]
10. CD10-positive myoepithelial cells are usually prominent around in situ lobular neoplasia of the breast and much less prominent or absent in DCIS.
Shousha S; Forbes G; Hopkins I; Wright JA
J Clin Pathol; 2016 Aug; 69(8):702-5. PubMed ID: 26862059
[TBL] [Abstract][Full Text] [Related]
11. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
12. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
Kővári B; Báthori Á; Cserni G
Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
[TBL] [Abstract][Full Text] [Related]
13. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.
Moritani S; Kushima R; Sugihara H; Bamba M; Kobayashi TK; Hattori T
Mod Pathol; 2002 Apr; 15(4):397-405. PubMed ID: 11950913
[TBL] [Abstract][Full Text] [Related]
14. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications.
Hilson JB; Schnitt SJ; Collins LC
Am J Surg Pathol; 2009 Feb; 33(2):227-32. PubMed ID: 18936688
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
